We are live on !
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
Turnover
55.09%
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter Est. Return
+35.34%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$213M
AUM Growth
-$6.7M
(-3%)
Cap. Flow
-$47.5M
Cap. Flow % of AUM
Cap. Flow %
-22.27%
Top 10 Holdings %
Top 10 Hldgs %
8.05%
Holding
403
New
118
Increased
30
Reduced
151
Closed
104
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lear
LEA
|
+$1.16M |
| 2 |
Americold
COLD
|
+$1.09M |
| 3 |
Republic Services
RSG
|
+$1.07M |
| 4 |
Howmet Aerospace
HWM
|
+$1.07M |
| 5 |
Intercontinental Exchange
ICE
|
+$911K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$1.96M |
| 2 |
Helen of Troy
HELE
|
+$1.64M |
| 3 |
FTI Consulting
FCN
|
+$1.55M |
| 4 |
Spire
SR
|
+$1.54M |
| 5 |
McKesson
MCK
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.91% |
| 2 | Technology | 16.4% |
| 3 | Miscellaneous | 12.97% |
| 4 | Financials | 12.03% |
| 5 | Industrials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CLDR
26
DELISTED
Cloudera, Inc.
CLDR
| $1.09M | 0.51% |
85,629
-13,314
| -13% | -$128K |
2020 Q1
1 quarter
|
|
27
Halozyme
HALO
$14.9B
| $1.08M | 0.51% |
40,453
-6,279
| -13% | -$142K |
2018 Q4
6 quarters
|
|
28
Patrick Industries
PATK
$2.41B
| $1.07M | 0.5% |
+26,168
| New | +$793K |
2020 Q2
0 quarters
|
|
29
Clearway Energy Class C
CWEN
$3.98B
| $1.06M | 0.5% |
46,074
-7,147
| -13% | -$151K |
2019 Q4
2 quarters
|
|
30
DELISTED
Chart Industries
GTLS
| $1.06M | 0.5% |
+21,872
| New | +$802K |
2020 Q2
0 quarters
|
|
31
Installed Building Products
IBP
$5.64B
| $1.06M | 0.5% |
15,393
-2,389
| -13% | -$132K |
2019 Q1
5 quarters
|
|
32
Mercury Systems
MRCY
$4.98B
| $1.06M | 0.49% |
13,421
-5,762
| -30% | -$472K |
2019 Q4
2 quarters
|
|
33
Commercial Metals
CMC
$7.25B
| $1.04M | 0.49% |
51,162
-7,938
| -13% | -$136K |
2019 Q3
3 quarters
|
|
34
CACI
CACI
$14.9B
| $1.03M | 0.48% |
4,759
-2,443
| -34% | -$584K |
2018 Q1
9 quarters
|
|
35
Teradyne
TER
$46.3B
| $1.02M | 0.48% |
12,090
-9,408
| -44% | -$631K |
2019 Q2
4 quarters
|
|
36
DELISTED
Zynex
ZYXI
| $1.02M | 0.48% |
+45,007
| New | +$754K |
2020 Q2
0 quarters
|
|
37
Clearwater Paper
CLW
$210M
| $1.02M | 0.48% |
28,118
-4,394
| -14% | -$122K |
2020 Q1
1 quarter
|
|
38
DELISTED
MODEL N, INC.
MODN
| $1.02M | 0.48% |
29,234
-4,537
| -13% | -$132K |
2020 Q1
1 quarter
|
|
39
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10B
| $1.01M | 0.47% |
43,062
+2,208
| +5% | +$49.5K |
2018 Q2
8 quarters
|
|
40
National Beverage
FIZZ
$3.28B
| $1M | 0.47% |
32,906
-5,110
| -13% | -$138K |
2020 Q1
1 quarter
|
|
41
Workiva
WK
$4.5B
| $998K | 0.47% |
+18,661
| New | +$765K |
2020 Q2
0 quarters
|
|
42
Schwab Fundamental International Small Company Index ETF
FNDC
$3.06B
| $996K | 0.47% |
36,160
+1,700
| +5% | +$44.6K |
2018 Q2
8 quarters
|
|
43
Pacira BioSciences
PCRX
$1.45B
| $981K | 0.46% |
18,699
-2,903
| -13% | -$121K |
2020 Q1
1 quarter
|
|
44
Morgan Stanley
MS
$297B
| $977K | 0.46% |
20,225
-3,968
| -16% | -$167K |
2019 Q4
2 quarters
|
|
45
PennyMac Financial
PFSI
$3.35B
| $974K | 0.46% |
23,312
-3,618
| -13% | -$115K |
2019 Q3
3 quarters
|
|
|
SBNY
46
DELISTED
Signature Bank
SBNY
| $974K | 0.46% |
9,111
-4,471
| -33% | -$440K |
2020 Q1
1 quarter
|
|
47
Schwab Fundamental International Large Company Index ETF
FNDF
$25.8B
| $972K | 0.46% |
40,937
+1,928
| +5% | +$43.5K |
2018 Q2
8 quarters
|
|
48
Cirrus Logic
CRUS
$5.7B
| $968K | 0.45% |
15,673
-8,189
| -34% | -$560K |
2019 Q3
3 quarters
|
|
49
Digital Turbine
APPS
$1.29B
| $964K | 0.45% |
+76,654
| New | +$535K |
2020 Q2
0 quarters
|
|
50
Box
BOX
$5.95B
| $963K | 0.45% |
46,374
-7,186
| -13% | -$126K |
2020 Q1
1 quarter
|
|
Similar funds
RCM
RI
361 Capital's Q2 2020 Portfolio in Review
As of Q2 2020, 361 Capital held 403 positions worth $213M, down 3% from $220M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
361 Capital withdrew a net $47.5M in Q2 2020, closing 104 positions and reducing 151 holdings. Its most notable exit was Chemed, an estimated $1.96M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, 361 Capital opened a new position in Lear worth $1.27M.
- 361 Capital's largest Q2 2020 buy was Lear: 11,650 shares worth $1.27M.
- 361 Capital added most to DaVita in Q2 2020, an estimated $427K increase.
- 361 Capital's biggest Q2 2020 reduction was Williams Companies, cutting an estimated $1.41M.
- 361 Capital fully exited Chemed in Q2 2020, selling an estimated $1.96M.
- 361 Capital's ten largest holdings make up 8.1% of its $213M portfolio in Q2 2020.
- 361 Capital opened 118 new positions and closed 104 in Q2 2020.
- 361 Capital's portfolio value fell 3% quarter-over-quarter to $213M.
Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.